Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Ramsay Generale dente's accounts receivables for the quarter that ended in Dec. 2025 was €485 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Ramsay Generale dente's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was €-43.44.
Ramsay Generale dente Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Ramsay Generale dente's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Ramsay Generale dente's accounts receivable are only considered to be worth 75% of book value:
Ramsay Generale dente's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Ramsay Generale dente Accounts Receivable Related Terms
Ramsay Generale dente Accounts Receivable Historical Data
* Premium members only.
The historical data trend for Ramsay Generale dente's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Generale dente (FRA:GD6) has a Accounts Receivable of €485 Mil as of Dec. 2025. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Ramsay Generale dente and its competitors.
Is Ramsay Generale dente's Accounts Receivable too high?
Ramsay Generale dente's current Accounts Receivable is €485 Mil. Overall, Ramsay Generale dente has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Ramsay Generale dente's Accounts Receivable compare to HCA and THC?
Ramsay Generale dente's Accounts Receivable of €485 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Healthcare Providers & Services company?
A good Accounts Receivable depends on the Healthcare Providers & Services industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Ramsay Generale dente and its competitors. Ramsay Generale dente's current Accounts Receivable is €485 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Generale dente stock overvalued right now?
Ramsay Generale dente (FRA:GD6) has a current Accounts Receivable of €485 Mil. The stock's GF Value™ is €21.61, compared to a current price of €10.45 — trading 51.6% below its estimated fair value. The current Accounts Receivable is €485 Mil. Ramsay Generale dente's overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Ramsay Generale dente (FRA:GD6), the current Accounts Receivable is €485 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Generale dente (FRA:GD6) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Generale dente stock appears to be undervalued.
The current stock price of €10.45 is trading 51.6% below its estimated GF Value™ of €21.61.
Key valuation signals for FRA:GD6:
Accounts Receivable: €485 Mil
GF Value™: €21.61 vs. price of €10.45 (51.6% below fair value)
No single metric tells the full story. See the FRA:GD6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.
71GF Score
Get the complete analysis for FRA:GD6
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:GD6 has been successfully added to your 
